Cactus, Inc. Class A WHD 深 滬
已收盤 02-06 16:00:00 美东时间
58.00
+1.470
+2.60%
華盛通- 最 高58.67
- 今 開56.94
- 成交量 123.67万股
- 最 低 56.855
- 昨 收 56.53
- 總市值 46.31亿
- 52周最高 60.84
- 市盈率 靜 20.91
- 換手率 1.55%
- 52周最低 33.06
- 委 比 95.12%
- 總股本 7984.75万
- 歷史最高 69.34
- 量 比 1.37
- 振 幅 3.21%
- 歷史最低 5.57
- 每 手 1
- 風險率 6.01%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Cactus Completes Transformational Surface Pressure Control Acquisition
Cactus ( ($WHD) ) has shared an announcement. On January 2, 2025, Cactus, Inc. ...
01-03 05:18
Baker Hughes, Cactus Announce Closing of Surface Pressure Control Joint Venture
Baker Hughes finalized a joint venture with Cactus, Inc. subsidiary, contributing its surface pressure control (SPC) product line. The transaction brings $344.5 million in cash proceeds, strengthening Baker Hughes' balance sheet and liquidity. Cactus holds a 65% stake, while Baker Hughes retains 35%. This aligns with Baker Hughes' strategy to enhance portfolio management, cash flow durability, and capital efficiency.
01-02 12:00
Cheap smaller cap stocks that promise acceleration in fundamentals – BofA
BofA analysts outlined a list of inexpensive small- and mid-cap stocks with accelerating fundamentals. These are Russell 2000 (IWM) stocks that have cheap valuations along with positive revisions and ...
2025-12-20 00:57
美股大行评级 | 德银首予Coinbase"买入"评级，目标价340美元；AERO获多家机构首予超配评级；大摩维持苹果"超配"评级，目标价升至315美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从9美元升至10美元；摩根大通：上调Recursion Pharmaceuticals评级至"超配"，目标价从10美元升至11美元
2025-12-18 10:54
美股大行评级 | 绩后分化！甲骨文遭14家大行集体下调目标价；新思科技、Planet获多家机构上调目标价！
今日重点评级关注：HC Wainwright & Co.：维持Moleculin Biotech"买入"评级，目标价从4美元升至22美元；HC Wainwright & Co.：上调Soluna Holdings评级至"买入"，目标价5美元
2025-12-12 10:24
Citigroup Upgrades Cactus to Buy, Raises Price Target to $55
Citigroup analyst Scott Gruber upgrades Cactus (NYSE:WHD) from Neutral to Buy and raises the price target from $45 to $55.
2025-12-11 22:16
Cactus to Acquire Baker Hughes Surface Business
Cactus ( ($WHD) ) has shared an update. Cactus, Inc. recently completed the acq...
2025-11-11 06:57
美股大行评级 | 苹果、亚马逊、Cloudflare、西部数据、Twilio等获十多家机构集体上调目标价；杰富瑞首予Cloudflare"持有"评级，目标价250美元
今日重点评级关注：康托·菲茨杰拉德：维持Cabaletta Bio"超配"评级，目标价从15美元升至30美元；HC Wainwright & Co.：维持Invivyd"买入"评级，目标价从5美元升至10美元
2025-11-03 20:20
